Pantoprazole (BY10232) is an orally active and potent proton pump inhibitor (PPI). Pantoprazole, a substituted benzimidazole, is a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. Pantoprazole improves pH stability and has anti-secretory, anti-ulcer activities. Pantoprazole significantly increased tumor growth delay combined with Doxorubicin (HY-15142).

• Application:COVID-19-immunoregulation
• CAS:102625-70-7
• Formula:C16H15F2N3O4S
• Manufacturer:MedChemExpress
• Sinonims:BY1023; SKF96022
• Molecular mass:383.37